Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances

Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances

10.1136/jnnp-2021-327370

Saved in:

Bibliographic Details
Main Authors:	Chong, Joyce R, Ashton, Nicholas J, Karikari, Thomas K, Tanaka, Tomotaka, Scholl, Michael, Zetterberg, Henrik, Blennow, Kaj, Chen, Christopher P, Lai, Mitchell KP
Other Authors:	PHARMACOLOGY
Format:	Review
Language:	English
Published:	BMJ PUBLISHING GROUP 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Clinical Neurology Psychiatry Surgery Neurosciences & Neurology Alzheimer's disease dementia amyloid PLASMA NEUROFILAMENT LIGHT A-BETA PERFORMANCE OLIGOMERS BURDEN
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/241005
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease
by: Chong, JR, et al.
Published: (2023)

AMYLOID PRECURSOR PROTEIN SIGNALING IN PHYSIOLOGY AND ALZHEIMER?S DISEASE
by: JOANITA BINTE JASMEN
Published: (2016)

Absence of A673T amyloid-β precursor protein variant in alzheimer's disease and other neurological diseases
by: Ting, S.K.S., et al.
Published: (2014)

Neuropsychiatry - An emerging field
by: Lee, T.-S., et al.
Published: (2014)

The roles of amyloid precursor protein (APP) in neurogenesis, implications to pathogenesis and therapy of alzheimer Disease (AD)
by: Zhou, Z.-D., et al.
Published: (2014)

The roles of amyloid precursor protein (APP) in neurogenesis, implications to pathogenesis and therapy of alzheimer Disease (AD)
by: Zhou Z.-D., et al.
Published: (2018)

Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future
by: Mok, Vincent CT, et al.
Published: (2022)

Pulmonary embolism after manual muscle testing in an incomplete paraplegic patient: A case report
by: Kovindha A., et al.
Published: (2015)

Prevalence of pressure ulcers in Thai wheelchair users with chronic spinal cord injuries
by: Kovindha A., et al.
Published: (2015)

Difficulty in moving around in a wheelchair as a presenting symptom of left atrial myxoma in a chronic paraplegic patient: A case report
by: Kovindha,A., et al.
Published: (2015)

Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration
by: Beaman, Charles, et al.
Published: (2022)

Upregulated blood miR-150-5p in alzheimer's disease dementia is associated with cognition, cerebrospinal fluid amyloid-β, and cerebral atrophy
by: Chia, Sook Yoong, et al.
Published: (2023)

Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias
by: Low, Clara YB, et al.
Published: (2021)

Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
by: Chai, Yuek Ling, et al.
Published: (2021)

Truncated Tau caused by intron retention is enriched in Alzheimer’s disease cortex and exhibits altered biochemical properties
by: Ngian, ZK, et al.
Published: (2023)

Modulation of energy homeostasis by amyloid precursor protein (APP)
by: CHUA LI MIN
Published: (2011)

The Amyloid-beta Pathway in Alzheimer's Disease
by: Hampel, Harald, et al.
Published: (2022)

Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with A beta burden
by: Tan, Michelle GK, et al.
Published: (2021)

The Role of Hydrogen Sulfide in the Central Nervous System: Implications in the Treatment of Alzheimer's Disease
by: BHUSHAN VIJAY NAGPURE
Published: (2015)

ENDOSOMAL DYSFUNCTION IN ALZHEIMER'S DISEASE: ROLE OF THE CYTOSOLIC DOMAIN OF THE AMYLOID PRECURSOR PROTEIN (APP)
by: TSE MAYING TSEMAY
Published: (2019)

THERAPEUTIC POTENTIAL OF CHIMERIC AMYLOID-BETA PRECURSOR PROTEIN INTRACELLULAR DOMAIN MUTANT IN ALZHEIMER'S DISEASE
by: PAWAN KUMAR
Published: (2020)

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia
by: Park, Kee Hyung, et al.
Published: (2022)

Reducing pathological accumulations of phosphorylated Neurofilament-H through modulation of Pin1 activity: Implications in Amyotrophic Lateral Sclerosis
by: CHARLENE PRISCILLA POORE
Published: (2014)

Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease
by: Chai, Yuek Ling, et al.
Published: (2021)

Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease
by: Chong, Joyce R, et al.
Published: (2021)

Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease
by: Lai, MK, et al.
Published: (2021)

White matter hyperintensities are related to pain intensity in an outpatient memory clinic population: preliminary findings
by: Binnekade, Tarik T, et al.
Published: (2022)

Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia
by: Lee, Jasinda H, et al.
Published: (2021)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
by: Wang, H.-F., et al.
Published: (2021)

Loss of [H-3]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis
by: Tsang, SWY, et al.
Published: (2021)

Application of optogenetic amyloid-β distinguishes between metabolic and physical damage in neurodegeneration
by: Hsien, L.C., et al.
Published: (2021)

Microglial in neurodegenerative disorders: Emphasis on Alzheimer's disease
by: McRae, A., et al.
Published: (2012)

Regulated trafficking of APP by SORLA in Alzheimer's disease
by: Lao, Angelyn R., et al.
Published: (2012)

ASSOCIATION OF TELOMERE LENGTH WITH AMYLOID PATHOLOGY IN CEREBRUM AND ITS ROLE IN DEMENTIA
by: GRISHMA RANE
Published: (2017)

Dissociative paraplegia after epidural anesthesia: A case report
by: Hirjak, D., et al.
Published: (2016)

Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment
by: Chua, Xin Ying, et al.
Published: (2021)

A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease
by: Tsang, Shirley W, et al.
Published: (2021)

Coordination chemistry of ligands: insights into the design of amyloid beta/tau-PET imaging probes and nanoparticles-based therapies for Alzheimer's disease
by: Selvan, Subramanian Tamil, et al.
Published: (2022)

Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups
by: Lo, Jessica W, et al.
Published: (2022)

Selective loss of P2Y(2) nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology
by: Lai, Mitchell KP, et al.
Published: (2021)